Lisa Anson, Chief Executive Officer of Redx Pharma, commented : “We are excited by the potential of porcupine inhibition as a novel approach to tackling fibrotic-associated diseases where there is
OKYO Pharma LTD (OKYO.L) Issue of convertible loan notes to raise £3,500,000
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS
Is OKYO Pharma (OKYO.L) the next Tiziana Life Sciences (TILS.L)
Pharma stocks have strengthened in 2020
Open Orphan PLC (LON:ORPH) New hVIVO contract signed with a European Biotech Company
Initial study for the provision of a RSV human challenge study
Concepta Plc (AIM:CPT) Assembly held in Shanghai to showcase myLotus
Concepta plc (AIM: CPT), the UK healthcare company and developer of a proprietary product targeted at the mobile health market with a primary focus on women’s fertility, is pleased to
ValiRx Plc (AIM:VAL) ValiSeek Clinical Development Update
ValiRx Plc (AIM: VAL), the clinical stage biotechnology company, is pleased to provide a positive update on the clinical progress of VAL401, the anti-cancer compound developed by ValiSeek, the joint
Tiziana Life Sciences (AIM:TILS) Phase II Clinical Trial Update
Tiziana Life Sciences plc (AIM: TILS), a clinical stage biotechnology company developing targeted drugs for cancer and inflammatory diseases, today announces that milciclib, a small molecular pan-inhibitor of cyclin dependent
ABM Interviews CEO Satu Vainikka of Valirx PLC (AIM:VAL)
ABM from Share Talk interviews Satu Vainikka – CEO of Valirx PLC